TY - JOUR
T1 - Integrative oncology
T2 - Addressing the global challenges of cancer prevention and treatment
AU - Mao, Jun J.
AU - Pillai, Geetha Gopalakrishna
AU - Andrade, Carlos Jose
AU - Ligibel, Jennifer A.
AU - Basu, Partha
AU - Cohen, Lorenzo
AU - Khan, Ikhlas A.
AU - Mustian, Karen M.
AU - Puthiyedath, Rammanohar
AU - Dhiman, Kartar Singh
AU - Lao, Lixing
AU - Ghelman, Ricardo
AU - Cáceres Guido, Paulo
AU - Lopez, Gabriel
AU - Gallego-Perez, Daniel F.
AU - Salicrup, Luis Alejandro
N1 - Funding Information:
Jun J. Mao and Memorial Sloan Kettering Cancer Center (MSK) staff are supported in part by an MSK National Institutes of Health/National Cancer Institute Cancer Center grant (P30 CA008748) and by the Herbal Education and Research in Oncology Program made possible by the Laurance S. Rockefeller Foundation. Jun J. Mao reports research funding provided to MSK from Tibet Cheezheng Tibetan Medicine Company, Ltd. Lorenzo Cohen receives royalties from the book, . All remaining authors report no conflicts of interest. DISCLOSURES: Anticancer Living: Transform Your Life and Health With the Mix of Six
Publisher Copyright:
© 2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care. Integrative oncology provides a framework to research and integrate safe, effective TCIM alongside conventional cancer treatment and can help bridge health care gaps in delivering evidence-informed, patient-centered care. This growing field uses lifestyle modifications, mind and body therapies (eg, acupuncture, massage, meditation, and yoga), and natural products to improve symptom management and quality of life among patients with cancer. On the basis of this review of the global challenges of cancer control and the current status of integrative oncology, the authors recommend: 1) educating and integrating TCIM providers into the cancer control workforce to promote risk reduction and culturally salient healthy life styles; 2) developing and testing TCIM interventions to address cancer symptoms or treatment-related adverse effects (eg, pain, insomnia, fatigue); and 3) disseminating and implementing evidence-based TCIM interventions as part of comprehensive palliative and survivorship care so patients from all cultures can live with or beyond cancer with respect, dignity, and vitality. With conventional medicine and TCIM united under a cohesive framework, integrative oncology may provide citizens of the world with access to safe, effective, evidence-informed, and culturally sensitive cancer care.
AB - The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care. Integrative oncology provides a framework to research and integrate safe, effective TCIM alongside conventional cancer treatment and can help bridge health care gaps in delivering evidence-informed, patient-centered care. This growing field uses lifestyle modifications, mind and body therapies (eg, acupuncture, massage, meditation, and yoga), and natural products to improve symptom management and quality of life among patients with cancer. On the basis of this review of the global challenges of cancer control and the current status of integrative oncology, the authors recommend: 1) educating and integrating TCIM providers into the cancer control workforce to promote risk reduction and culturally salient healthy life styles; 2) developing and testing TCIM interventions to address cancer symptoms or treatment-related adverse effects (eg, pain, insomnia, fatigue); and 3) disseminating and implementing evidence-based TCIM interventions as part of comprehensive palliative and survivorship care so patients from all cultures can live with or beyond cancer with respect, dignity, and vitality. With conventional medicine and TCIM united under a cohesive framework, integrative oncology may provide citizens of the world with access to safe, effective, evidence-informed, and culturally sensitive cancer care.
KW - alternative
KW - and integrative medicine
KW - cancer prevention
KW - complementary
KW - global health
KW - health policy
KW - survivorship
UR - http://www.scopus.com/inward/record.url?scp=85118686669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118686669&partnerID=8YFLogxK
U2 - 10.3322/caac.21706
DO - 10.3322/caac.21706
M3 - Review article
C2 - 34751943
AN - SCOPUS:85118686669
SN - 0007-9235
VL - 72
SP - 144
EP - 164
JO - CA Cancer Journal for Clinicians
JF - CA Cancer Journal for Clinicians
IS - 2
ER -